Alkem Laboratories
VC Fund
Mumbai, India
Alkem Laboratories is a manufactures and sells pharmaceutical generics, formulations and active pharmaceutical ingredients (APIs) primarily in India and also in United States, Australia, UK. Alkem has been among the top ten pharmaceutical companies in India for the past 12 years.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Alkem Laboratories invests in
Stages Alkem Laboratories invests in
Countries Alkem Laboratories invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Manish Narang
|
|||
Rajesh Dubey
|
|||
Samprada Singh
|
|||
Investment Focus
Industry
- Biotechnology 2 (67%)
- Delivery 1 (33%)
- PropTech 1 (33%)
- Real Estate 1 (33%)
- Manufacturing 1 (33%)
Stage
- Seed 1 (33%)
- Series A 1 (33%)
- Venture - Series Unknown 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Manish Narang
President - Legal,Company Secretary and Compliance Officer
|
President - Legal,Company Secretary and Compliance Officer | Total investments: 0 | Find email | |
|
Rajesh Dubey
President, CFO
|
President, CFO | Total investments: 0 | Find email | |
|
Samprada Singh
Founder
|
Founder | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Enzene Biosciences
|
Delivering cost effective biosimilars by developing disruptive technologies, advanced analytics and state-of-the-art manufacturing facility. Being the most desired Biotech company to work for by creating an unparalleled work culture. Broadening the footprint of their innovative technologies through strategic global alliances. | $50.3M / Venture - Series Unknown / Jan 30, 2023 | |
Eyestem
|
Eyestem is a cell therapy company founded by a top-class management team consisting of clinical trial, cell therapy and ophthalmology experts. It also boasts a world class advisory board and we have built collaborations with pioneers and leaders in the space. Our long-term vision is to create a global and scalable cell therapy platform to treatincurable diseases. We are developing a cell therapy platform to produce consistent, quality products over the next few years, concentrating on in vitro efficacy and safety. | $6.4M / Series A / Aug 08, 2022 | |
Zapkey
|
Zapkey operates as a proptech and home sales guarantee platform. Zapkey provides its customers with guaranteed home sales within 3 months of the listing date, or they buy the property themselves. | $2M / Seed / Mar 02, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Alkem Laboratories invest in?
Alkem Laboratories invests primarily in Biotechnology, Delivery and PropTech startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Alkem Laboratories?
Public channels for Alkem Laboratories include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Alkem Laboratories?
The team at Alkem Laboratories includes Manish Narang (President - Legal,Company Secretary and Compliance Officer), Rajesh Dubey (President, CFO) and Samprada Singh (Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
